Opinion: The Flood Reduction Benefits of Wetlands

Conservationists and the insurance industry team up to model the economic benefits of marshes during hurricanes.

Written bySiddharth Narayan and Michael W. Beck
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Damage from Hurricane Sandy in Union Beach, New JerseyFLICKR, WAVIANThe ongoing devastation from Hurricane Harvey sadly reminds us of the risks of coastal living. We feel deeply for the communities in Harvey’s path. One of us (Sid Narayan) hails from a coastal city in south India that has seen its fair share of tragedy too, from annual cyclones to the 2004 Asian tsunami. Sid has spent his career as a coastal engineer trying to design solutions to reduce those risks. He has carved a niche as one of the small but growing number of engineers helping to show where natural solutions can contribute cost effectively to risk reduction. As a coastal ecologist, the other author (Mike Beck) has had to run from storms too, including once abandoning his boat and broken trailer in a swampy, roadside ditch in the Florida panhandle.

Over the past four years, our team has had the opportunity to look beyond coastal biodiversity and to work closely with the insurance sector to evaluate the benefits of coastal wetlands for flood risk reduction. With support from Lloyd’s of London and collaborators from RMS and Guy Carpenter and Company, we used the risk industry’s high-resolution flood models and extensive property-loss data to show that wetlands play a critical role in reducing risks from storms in the northeast United States.

Habitat restoration could pay for itself in savings.

In Scientific Reports today (August 31), we report from these industry models that during Hurricane Sandy marshes prevented USD$625 million in direct flood damages across 12 states, and reduced flood levels along several hundreds of kilometers of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies